Reassessing EpiPen Efficacy in Anaphylaxis

This chapter critically examines a recent paper questioning the effectiveness of EpiPens in preventing fatal anaphylaxis despite rising diagnoses and prescriptions. The speakers discuss various factors influencing these findings, such as overdiagnosis and incorrect treatment protocols, emphasizing the need for improved patient stratification. They also explore regional differences in prescribing practices and the implications of medical decision-making within the American healthcare system.